Why do methadone clinics give liquid methadone

Methadone and Co.

Summary and Outlook

Methaliq® is a finished medicinal product for the substitution treatment of opiate addicts, which has been on the market since May 2014, and whose use makes the prescription-based production of 1% methadone solutions unnecessary for pharmacies if a doctor prescribes it. Due to the good availability on the part of the manufacturer and the pharmaceutical wholesalers supplied, the advantage of ready-to-use and a consistently high quality ensured by means of modern industrial manufacturing techniques, the preparation solves the NRF formulation 29.1. as a drug therapy standard.

The market launch also offers pharmacists the opportunity to put their sometimes shown reluctance in the pharmaceutical care of opiate addicts to the test and, in view of the significantly reduced production costs, to participate in the allocation of methadone-containing substitution agents in visual reference. At the same time, the pharmacist makes a contribution to prevention by being perceived by addicts as a competent and trustworthy contact person and by being able to instruct those affected to adopt less risky behavior. An increased turn of the pharmacists towards socially marginalized groups would be seen by politics and the media as a sign of assuming social responsibility and could represent an important step on the way to securing the future of the existing and proven system of owner-managed public pharmacies.


[1] German Medical Association, quality assurance of substitution treatment for opiate addicts, as of June 16, 2010, www.bundesaerztekammer.de, sections: Doctors> Addiction medicine> Illegal drugs> Substitution-based treatment for opiate addicts> Quality assurance. Reading date 07/09/2014.

[2] Pfeiffer-Gerschel, T., Kipke, I., Flöter, S., Jakob, L., Budde, A., Rummel, C., 2013 report from the national REITOX hub to the EMCDDA. New developments and trends. Drug situation 2012/2013. Munich: German Monitoring Center for Drugs and Drug Addiction DBDD (2013)

[3] German Medical Association, substitution treatment for opiate addicts - new guidelines adopted. German Doctor bl. 11 (2010) A-476-477